What Do the Screening Trials Really Tell Us and Where Do We Go From Here?-Reference-Cited by-同舟云学术

What Do the Screening Trials Really Tell Us and Where Do We Go From Here?

Published:2014-05 Issue:2 Volume:41 Page:223-228
ISSN:0094-0143
Container-title:Urologic Clinics of North America
language:en
Short-container-title:Urologic Clinics of North America

Author:

Etzioni Ruth D.,Thompson Ian M.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Reconstructing prostate-specific antigen (PSA) testing patterns among black and white men in the US from Medicare claims and the National Health Interview Survey;Mariotto;Cancer,2007

2. Screening for prostate cancer: U.S. preventive services task force recommendation statement;Moyer;Ann Intern Med,2012

3. American Cancer Society guideline for the early detection of prostate cancer: update 2010;Wolf;CA Cancer J Clin,2010

4. Association AU. Early detection of prostate cancer: AUA guideline. 2013. Available at: http://www.auanet.org/education/guidelines/prostate-cancer-detection.cfm. Accessed February 10, 2014.

5. Mortality results from a randomized prostate-cancer screening trial;Andriole;N Engl J Med,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials;Health Technology Assessment;2023-08

2. UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis;Trials;2021-03-01

3. UKCTOCS Update: Applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis;2020-11-16

4. Personalized early detection and prevention of breast cancer: ENVISION consensus statement;Nature Reviews Clinical Oncology;2020-06-18

5. Development and initial clinical correlation of a DNA methylation‐based blood test for prostate cancer;The Prostate;2020-06-07